{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:59:10Z","timestamp":1789001950593,"version":"build-2803163510"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to determine the association between fluoroquinolones (FQs) use, the risk of <jats:italic>de novo<\/jats:italic> aortic aneurysm or dissection (AAD), and the prognosis of patients with pre-existing AAD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>We searched PubMed, EMBASE, CENTRAL, Scopus, and Web of Science on 31 March 2022. Observational studies that evaluated the association of FQs with AAD risk in the general population or FQs with the prognosis of patients with preexisting AAD and presented adjusted effect estimates were included. Two reviewers assessed study eligibility, extracted data, and assessed the risk of bias and certainty of evidence using GRADE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 13 included studies, 11 focused on the association of FQs with <jats:italic>de novo<\/jats:italic> AAD incidence, and only one study investigated the association of FQs with the patient with AAD prognosis. FQ use was associated with an increased risk of <jats:italic>de novo<\/jats:italic> AAD within 30 days (RR: 1.42; 95% CI: 1.11\u20131.81; very low certainty) and 60 days (RR: 1.44; 95% CI: 1.26\u20131.64; low certainty). Specifically, the association was significant when compared with amoxicillin, azithromycin, doxycycline, or no antibiotic use. Furthermore, patients with preexisting AAD exposure to FQ had an increased risk of all-cause mortality (RR: 1.61; 95% CI: 1.50\u20131.73; moderate certainty) and aortic-specific mortality (RR: 1.80; 95% CI: 1.50\u20132.15; moderate certainty), compared to the non-exposed FQ group within a 60-day risk period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>FQs were associated with an increased incidence of AAD in the general population and a higher risk of adverse outcomes in patients with preexisting AAD. Nevertheless, the results may be affected by unmeasured confounding factors. This should be considered by physicians contemplating using FQs in patients with aortic dilation and those at high risk of AAD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p>[<jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>], identifier [CRD42021230171].<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.949538","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T07:04:56Z","timestamp":1660028696000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Do fluoroquinolones increase aortic aneurysm or dissection incidence and mortality? A systematic review and meta-analysis"],"prefix":"10.3389","volume":"9","author":[{"given":"Can","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruan","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangzhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianzhou","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26237153","article-title":"Biological effects of quinolones: A family of broad-spectrum antimicrobial agents.","volume":"26","author":"Millanao","year":"2021","journal-title":"Molecules."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160938","article-title":"Fluoroquinolone antimicrobial drugs.","volume":"189","author":"Chan","year":"2017","journal-title":"CMAJ."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1086\/428055","article-title":"Antimicrobial safety: Focus on fluoroquinolones.","volume":"41","author":"Owens","year":"2005","journal-title":"Clin Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/11536360-000000000-00000","article-title":"Safety profile of the fluoroquinolones: Focus on levofloxacin.","volume":"33","author":"Liu","year":"2010","journal-title":"Drug Saf."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s40264-019-00828-z","article-title":"Fluoroquinolone use and the risk of collagen-associated adverse events: A systematic review and meta-analysis.","volume":"42","author":"Yu","year":"2019","journal-title":"Drug Saf."},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tox.2005.04.002","article-title":"Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells.","volume":"212","author":"Sendzik","year":"2005","journal-title":"Toxicology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s40264-013-0089-8","article-title":"Tendon injury and fluoroquinolone use: A systematic review.","volume":"36","author":"Stephenson","year":"2013","journal-title":"Drug Saf."},{"key":"B8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/jac\/dku507","article-title":"Association between oral fluoroquinolone use and the development of retinal detachment: A systematic review and meta-analysis of observational studies.","volume":"70","author":"Chui","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1877382601306010001","article-title":"The role of collagen in the aorta\u2019s structure.","volume":"6","author":"Berillis","year":"2013","journal-title":"Open Circ Vasc J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"109.e","DOI":"10.1016\/j.jtcvs.2018.08.079","article-title":"Induction of human aortic myofibroblast-mediated extracellular matrix dysregulation: A potential mechanism of fluoroquinolone-associated aortopathy.","volume":"157","author":"Guzzardi","year":"2019","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1016\/j.jtcvs.2020.09.069","article-title":"Ciprofloxacin accelerates aortic enlargement and promotes dissection and rupture in Marfan mice.","volume":"163","author":"LeMaire","year":"2020","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010077","article-title":"Fluoroquinolones and collagen associated severe adverse events: A longitudinal cohort study.","volume":"5","author":"Daneman","year":"2015","journal-title":"BMJ open."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1001\/jamainternmed.2015.5389","article-title":"Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone.","volume":"175","author":"Lee","year":"2015","journal-title":"JAMA Internal Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jacc.2018.06.067","article-title":"Oral fluoroquinolone and the risk of aortic dissection.","volume":"72","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k678","article-title":"Fluoroquinolone use and risk of aortic aneurysm and dissection: Nationwide cohort study.","volume":"360","author":"Pasternak","year":"2018","journal-title":"BMJ."},{"key":"B16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2018.12.012","article-title":"Short-term risk of aortoiliac aneurysm or dissection associated with fluoroquinolone use.","volume":"73","author":"Maumus-Robert","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/jamasurg.2020.6165","article-title":"Association of fluoroquinolone use with short-term risk of development of aortic aneurysm.","volume":"156","author":"Newton","year":"2021","journal-title":"JAMA Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1001\/jamainternmed.2020.4192","article-title":"Association of infections and use of fluoroquinolones with the risk of aortic aneurysm or aortic dissection.","volume":"180","author":"Dong","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1001\/jamainternmed.2020.4199","article-title":"Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection.","volume":"180","author":"Gopalakrishnan","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1001\/jamainternmed.2020.4191","article-title":"Observational study design challenges-the case of fluoroquinolones and aortic disease.","volume":"180","author":"DeGette","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jmii.2021.03.002","article-title":"Association of fluoroquinolones use with the risk of aortic aneurysm or aortic dissection: Facts and myths.","volume":"54","author":"Lai","year":"2021","journal-title":"J Microbiol Immunol Infect."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.1804","article-title":"Effect of ciprofloxacin on susceptibility to aortic dissection and rupture in mice.","volume":"153","author":"LeMaire","year":"2018","journal-title":"JAMA Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.jacc.2021.02.047","article-title":"Effects of fluoroquinolones on outcomes of patients with aortic dissection or aneurysm.","volume":"77","author":"Chen","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00151-21","article-title":"Outpatient fluoroquinolone prescription fills in the United States, 2014 to 2020: Assessing the impact of food and drug administration safety warnings.","volume":"65","author":"Buehrle","year":"2021","journal-title":"Antimicrob Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab538","article-title":"Ambulatory fluoroquinolone use in the United States, 2015-2019.","volume":"8","author":"Umarje","year":"2021","journal-title":"Open Forum Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1712","DOI":"10.1128\/AAC.01712-18","article-title":"Patients at risk for aortic rupture often exposed to fluoroquinolones during hospitalization.","volume":"63","author":"Frankel","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4597","article-title":"A guide to systematic review and meta-analysis of prognostic factor studies.","volume":"364","author":"Riley","year":"2019","journal-title":"BMJ."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors.","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5065","article-title":"Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: Systematic review of observational studies.","volume":"354","author":"Foroutan","year":"2016","journal-title":"BMJ."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h870","article-title":"Use of GRADE for assessment of evidence about prognosis: Rating confidence in estimates of event rates in broad categories of patients.","volume":"350","author":"Iorio","year":"2015","journal-title":"BMJ."},{"key":"B32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot.","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ."},{"key":"B33","author":"Higgins","year":"2021","journal-title":"Cochrane handbook for systematic reviews of Interventions version 6.2."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","article-title":"What\u2019s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes.","volume":"280","author":"Zhang","year":"1998","journal-title":"JAMA."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.108.817619","article-title":"Risk factors for abdominal aortic aneurysms: A 7-year prospective study: The Troms\u00f8 study, 1994-2001.","volume":"119","author":"Forsdahl","year":"2009","journal-title":"Circulation."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00134-019-05751-6","article-title":"Predictors of gastrointestinal bleeding in adult ICU patients: A systematic review and meta-analysis.","volume":"45","author":"Granholm","year":"2019","journal-title":"Intensive Care Med."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.664","article-title":"Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self-controlled case series analysis.","volume":"8","author":"Aspinall","year":"2020","journal-title":"Pharmacol Res Perspect."},{"key":"B38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/bcpt.13591","article-title":"Fluoroquinolones as a trigger for rupture of abdominal aortic aneurysm: A case-crossover analysis.","volume":"129","author":"Lawaetz Kristensen","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-02488-x","article-title":"Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: A nested case-control study.","volume":"22","author":"Son","year":"2022","journal-title":"BMC Cardiovasc Disord."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023267","article-title":"Association between aortic aneurysm and aortic dissection with fluoroquinolones use in patients with urinary tract infections: A population-based cohort study.","volume":"11","author":"Chen","year":"2022","journal-title":"J Am Heart Assoc."},{"key":"B41","year":"2022","journal-title":"FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1001\/jamasurg.2021.3026","article-title":"Concerns about study on fluoroquinolone use and risk of development of aortic aneurysm.","volume":"156","author":"Sterpetti","year":"2021","journal-title":"JAMA Surg."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.3023","article-title":"Concerns about study on fluoroquinolone use and risk of development of aortic aneurysm.","volume":"156","author":"Chen","year":"2021","journal-title":"JAMA Surg."},{"key":"B44","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40520-019-01267-7","article-title":"Aortic rupture in patient on oral therapy with levofloxacin.","volume":"32","author":"Campana","year":"2020","journal-title":"Aging Clin Exp Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/j.athoracsur.2020.04.044","article-title":"Fluoroquinolone-associated type A aortic dissection in alpha-1 anti-trypsin deficiency.","volume":"110","author":"Guzzardi","year":"2020","journal-title":"Ann Thorac Surg."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-3-10","article-title":"Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea.","volume":"3","author":"Reviglio","year":"2003","journal-title":"BMC Ophthalmol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/15376516.2010.529183","article-title":"Effect of fluoroquinolones on the expression of matrix metalloproteinase in debrided cornea of rats.","volume":"21","author":"Sharma","year":"2011","journal-title":"Toxicol Mech Methods."},{"key":"B48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s002040000203","article-title":"Ultrastructure of Achilles tendon from rats after treatment with fleroxacin.","volume":"75","author":"Shakibaei","year":"2001","journal-title":"Arch Toxicol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3892\/ijmm.2012.1150","article-title":"Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1.","volume":"30","author":"Bujor","year":"2012","journal-title":"Int J Mol Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA.","volume":"339","author":"Wu","year":"2013","journal-title":"Science."},{"key":"B51","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature12306","article-title":"cGAS produces a 2\u2032-5\u2032-linked cyclic dinucleotide second messenger that activates STING.","volume":"498","author":"Ablasser","year":"2013","journal-title":"Nature."},{"key":"B52","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.","volume":"339","author":"Sun","year":"2013","journal-title":"Science."},{"key":"B53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.119.041460","article-title":"Critical role of cytosolic DNA and its sensing adaptor STING in aortic degeneration, dissection, and rupture.","volume":"141","author":"Luo","year":"2020","journal-title":"Circulation."},{"key":"B54","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1751-1097.2010.00755.x","article-title":"Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics.","volume":"86","author":"Zhao","year":"2010","journal-title":"Photochem Photobiol."},{"key":"B55","first-page":"1262","article-title":"In vivo and in vitro chondrotoxicity of ciprofloxacin in juvenile rats.","volume":"25","author":"Li","year":"2004","journal-title":"Acta Pharmacol Sin."},{"key":"B56","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/03635465000280031401","article-title":"The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism.","volume":"28","author":"Williams","year":"2000","journal-title":"Am J Sports Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0002-9610(98)00056-7","article-title":"Surgical treatment of infected aortic aneurysm.","volume":"175","author":"Moneta","year":"1998","journal-title":"Am J Surg."},{"key":"B58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejvs.2020.09.004","article-title":"Editor\u2019s choice \u2013 European society for vascular surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms.","volume":"57","author":"Wanhainen","year":"2019","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B59","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1370\/afm.2673","article-title":"Association between third-generation fluoroquinolones and Achilles Tendon rupture: A self-controlled case series analysis.","volume":"19","author":"Chinen","year":"2021","journal-title":"Ann Fam Med."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90692-8","article-title":"The association between fluoroquinolones and aortic dissection and aortic aneurysms: A systematic review and meta-analysis.","volume":"11","author":"Wee","year":"2021","journal-title":"Sci Rep."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10060697","article-title":"The association between the risk of aortic aneurysm\/aortic dissection and the use of fluroquinolones: A systematic review and meta-analysis.","volume":"10","author":"Lai","year":"2021","journal-title":"Antibiotics (Basel)."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-020-01354-y","article-title":"Relationship between fluoroquinolones and the risk of aortic diseases: A meta-analysis of observational studies.","volume":"20","author":"Dai","year":"2020","journal-title":"BMC Cardiovasc Disord."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.amjmed.2017.06.029","article-title":"Aortic dissection and aortic aneurysms associated with fluoroquinolones: A systematic review and meta-analysis.","volume":"130","author":"Singh","year":"2017","journal-title":"Am J Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/pds.5019","article-title":"A quantitative bias analysis of the confounding effects due to smoking on the association between fluoroquinolones and risk of aortic aneurysm.","volume":"29","author":"Zhang","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B65","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/bcp.13879","article-title":"Clinical implications of the association between fluoroquinolones and tendon rupture: The magnitude of the effect with and without corticosteroids.","volume":"85","author":"Persson","year":"2019","journal-title":"Br J Clin Pharmacol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.949538\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T07:05:02Z","timestamp":1660028702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.949538\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":65,"alternative-id":["10.3389\/fcvm.2022.949538"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.949538","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"article-number":"949538"}}